Author pages are created from data sourced from our academic publisher partnerships and public sources.
Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer.
CONTEXT High-intensity focussed ultrasound (HIFU) is an emerging minimally invasive treatment option for prostate cancer. OBJECTIVE Our aim was to assess the efficacy and safety of HIFU in both… Expand
Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults
A sufficient plasma level of fibrinogen is critical for the formation of a fibrin clot and haemostasis in both the perioperative setting and in massive haemorrhage. We assessed the efficacy and… Expand
Artificial total disc replacement versus fusion for the cervical spine: a systematic review
Cervical total disc replacement (CTDR) has been increasingly used as an alternative to fusion surgery in patients with pain or neurological symptoms in the cervical spine who do not respond to… Expand
SummaryDespite the large availability of diagnostic tests and procedures and their importance to medicine, evidence for their appropriate use is often limited. Unfortunately, the evaluation of tests… Expand
Pre-coverage assessments of new hospital interventions on Austria: methodology and 3 years of experience.
- Philipp Mad, Sabine Geiger-Gritsch, Gerda Hinterreiter, Stefan Mathis-Edenhofer, Claudia Wild
- International journal of technology assessment in…
- 1 April 2012
OBJECTIVES A new decision-making process was set up by the Austrian Ministry of Health to regulate coverage of new proposed Extra Medical Services (EMS; German: Medizinische Einzel-Leistung [MEL]) in… Expand
Corrigendum to "Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer" [Eur Urol 2010;58:803-15].
Marisa Warmuth *, Tim Johansson , Philipp Mad c a Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria b Institute of General Practice, Family Medicine and Preventive… Expand
Haemocomplettan® P alone or in combination with Fibrogammin® P in acquired hypofibrinogenemia
Haemocomplettan® P (fibrinogen concentrate) and Fibrogammin® P (factor XIII concentrate) have been licensed in Austria since 1994 and 2000, respectively, despite a lack of evidence proving their… Expand
- Open Access
Systematische Übersichtsarbeiten und Meta-Analysen
SummaryOver the past years, systematic reviews and meta-analyses have led to significant changes in clinical medicine and health policy. To date, they can be viewed as the most objective instruments… Expand
Telemonitoring for patients with chronic heart failure
- P. Mad
- 1 April 2007
Randomisiert kontrollierte Studien
SummaryNowadays the Randomised Controlled Trial (RCT) is seen as the gold standard for estimating the effectiveness of an observed intervention, achieving the highest hierarchy of evidence of primary… Expand